16 December 2024
De Brauw advises underwriters on NewAmsterdam Pharma's USD 479 million public offering of shares and pre-funded warrants
De Brauw advised the underwriters on the upsized USD 479 million public offering of shares and pre-funded warrants by NASDAQ listed NewAmsterdam Pharma Company N.V.